Logistic Regression of Risk Factors for Platelet Transfusions
| . | β . | SE . | χ2 . | P . | OR . | 95% CI . |
|---|---|---|---|---|---|---|
| Platelet transfusions | ||||||
| Intercept | 3.94 | .24 | 252 | <.001 | — | |
| High-risk chemotherapy* | 1.21 | .38 | 10.1 | .001 | 3.38 | 1.77-6.46 |
| d1 lymphocyte count ≤700/μL | 1.21 | .30 | 156.1 | .001 | 3.37 | 1.77-6.44 |
| PS >1 | 0.80 | .31 | 6.6 | .01 | 2.23 | 1.22-4.11 |
| d1 platelet count <150,000/μL | 1.46 | .32 | 20.3 | <.001 | 4.30 | 1.93-9.61 |
| . | β . | SE . | χ2 . | P . | OR . | 95% CI . |
|---|---|---|---|---|---|---|
| Platelet transfusions | ||||||
| Intercept | 3.94 | .24 | 252 | <.001 | — | |
| High-risk chemotherapy* | 1.21 | .38 | 10.1 | .001 | 3.38 | 1.77-6.46 |
| d1 lymphocyte count ≤700/μL | 1.21 | .30 | 156.1 | .001 | 3.37 | 1.77-6.44 |
| PS >1 | 0.80 | .31 | 6.6 | .01 | 2.23 | 1.22-4.11 |
| d1 platelet count <150,000/μL | 1.46 | .32 | 20.3 | <.001 | 4.30 | 1.93-9.61 |
*See the Patients and Methods.